Rigel Pharmaceuticals (RIGL) Q1 2026 Earnings

3MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
0.09
4.57
9.06
13.54

Details

Expected EPS
1.201457
Actual EPS
13.54
Surprise EPS
12.34
Surprise Percent
+1,026.97%

Description

Rigel Pharmaceuticals (RIGL) has reported earnings of 13.54 per share for Q1 2026.

0 Comments

Share your thoughts